Pharmacokinetic modeling as a tool for biological monitoring
- 1 January 1993
- journal article
- Published by Springer Nature in Internationales Archiv für Arbeitsmedizin
- Vol. 65 (S1) , S53-S59
- https://doi.org/10.1007/bf00381308
Abstract
The relationships between biological indicators and exposure or tissue burdens are determined by the pharmacokinetic behaviour of the chemical. They can be studied by pharmacokinetic models of various types. Simple pharmacokinetic models are used here to describe general relationships valid for large groups of chemicals or situations. Important parameters to consider are the half-life of the biological indicator, the individual variability and the exposure variability. Biological sampling strategies are presented for monitoring of groups of workers, or individual workers. For specific chemicals, mainly solvents, more elaborate models can be developed, i.e., physiologically-based pharmacokinetic models including physiological, metabolic and physico chemical parameters. Such models are useful to describe the influence of confounding factors. Physiologically-based pharmacokinetic models can also be developed for metals and metalloids. Antimony is presented here as an example. In conclusion, pharmacokinetic modeling brings much information on sampling time, sample size, limit values, effect of physical workload and of individual physiological parameters.Keywords
This publication has 9 references indexed in Scilit:
- Statistical Control Charts: A Technique for Analyzing Industrial Hygiene DataApplied Occupational and Environmental Hygiene, 1991
- Evaluation of Concomitant Biological and Air Monitoring ResultsApplied Occupational and Environmental Hygiene, 1991
- Experimental and human studies on antimony metabolism: their relevance for the biological monitoring of workers exposed to inorganic antimony.Occupational and Environmental Medicine, 1991
- Dermal absorption potential of industrial chemicals: Criteria for skin notationAmerican Journal of Industrial Medicine, 1990
- Variability in biological monitoring of organic solvent exposure. II. Application of a population physiological model.Occupational and Environmental Medicine, 1989
- Variability in biological monitoring of solvent exposure. I. Development of a population physiological model.Occupational and Environmental Medicine, 1989
- Rationale and Recommendations for Particle Size-Selective Sampling in the WorkplaceApplied Industrial Hygiene, 1986
- DEVELOPMENT AND APPLICATION OF A MODEL FOR ESTIMATING ALVEOLAR AND INTERSTITIAL DUST LEVELS *Annals of Occupational Hygiene, 1985
- RENAL CLEARANCE OF PENTAVALENT ANTIMONY (SODIUM STIBOGLUCONATE)The Lancet, 1980